Delivery Order SPE2DB20D2104-SPE2DB25FMLAY
Award Date
3/13/25
Potential Completion Date
3/14/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,017.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of LIALDA DR 1.2 GM TABLET 120S. The contract has a performance period through January 17, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,714.39 firm fixed-price delivery order is for the supply of LIALDA DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of October 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566760943 - LIALDA DR 1.2 GM TABLET 120S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,922.17 and a completion date of December 19, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,157.27 Firm Fixed Price Delivery Order is for the supply of LIALDA DR 1.2 GM TABLET 120S, a medication used to treat ulcerative colitis. The contract has an ultimate completion date of February 17, 2023 and was awarded on February 16, 2023. This contract is not designated as a set-aside and appears to be part...
This federal contract award is for the delivery of Lialda DR 1.2 GM Tablet (120 count) to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,350.19 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 31, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,497.49, is for the supply of Lialda DR 1.2 GM Tablet 120S, a medication used to treat ulcerative colitis. The contract has a firm fixed price and an ultimate completion date of March 17, 2023. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,696.67 contract is for the supply of 120 tablets of the drug Lialda (mesalamine 1.2 gram) to support military and federal healthcare programs. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,420.36 to Amerisourcebergen Drug Corporation for 120 tablets of 1.2 gm LIALDA DR, to be delivered from its Conshohocken, Pennsylvania facility by August 23, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. The Defense Logistics Agency manages the Department of Defense's global logistics operations, including procuring and providing medical supplies to support the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,178.58, is for the delivery of 120 tablets of the pharmaceutical product Mesalamine DR 1.2 GM. The contract has a completion date of February 26, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,658.22, is for the delivery of LYBALVI 20-10 MG TABLET UU 30S, a medical supply product. The contract has a period of performance through May 8, 2024 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract...